EOLS - Evolus, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$15.00
DETAILS
HIGH:
$17.00
LOW:
$13.00
MEDIAN:
$15.00
CONSENSUS:
$15.00
UPSIDE:
146.31%
About Evolus, Inc. (https://www.evolus.com)
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| David Moatazedi | President, Chief Executive Officer & Director | 1978 | $1,228,948 USD |
| Rui Avelar C.CFP Dip.SportMed | Chief Medical Officer and Head of Research & Development | 1962 | $730,167 USD |
| Tatjana Mitchell | Chief Financial Officer | – | $711,398 USD |
| Tomoko Yamagishi-Dressler | Chief Marketing Officer | 1965 | $677,374 USD |
| Jeffrey J. Plumer | Corporate Secretary | – | – |
| Jessica Novak | Senior Vice President of Human Resources | – | – |
| Kurt Knab | Senior Vice President of Sales | – | – |
| Nareg Sagherian | Head of Global Investor Relations & Corporate Communications | – | – |